The present application is concerned with a solid slow release pharmaceutical dosage unit. More specifically, the invention is directed to a tablet form prepared by direct compression of cross-linked amylose (CLA) having a definite cross-linking degree, .alpha.-amylase and a pharmaceutical agent. The...http://www.google.ca/patents/US5603956?utm_source=gb-gplus-sharePatent US5603956 - Cross-linked enzymatically controlled drug release
